TITLE

Current status of hepatic resection for hepatocellular carcinoma

AUTHOR(S)
Yanaga, Katsuhiko
PUB. DATE
October 2004
SOURCE
Journal of Gastroenterology;2004, Vol. 39 Issue 10, p919
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide. For this disease, a variety of therapeutic measures have been applied, including hepatic resections, total hepatectomy followed by allografting, transarterial chemoembolization, and percutaneous tumor ablative therapy by ethanol, microwave coagulation, and radiofrequency ablation. This article focuses on the current status of hepatic resections for HCC.
ACCESSION #
14932758

 

Related Articles

  • Totally laparoscopic hepatectomy exposing the vessels around the tumor intended to secure the surgical margin. Honda, Goro; Kurata, Masanao; Okuda, Yukihiro; Kobayashi, Shin; Sakamoto, Katsunori // Surgical Endoscopy;Apr2014, Vol. 28 Issue 4, p1331 

    Anatomical hepatectomy (AH) is basically not required for metastatic tumors in terms of oncology, but is required for hepatocellular carcinoma [-]; however, the surgeon cannot secure the surgical margin by palpation via a laparoscopic approach. Therefore, AH or partial hepatectomy exposing the...

  • The Role of Portal Vein Embolization Prior to Hepatic Resection for Primary and Secondary Hepatic Malignancies. Tashiro, Seiki; Miyake, Hidenori; Yoshioka, Kazuo // European Journal of Clinical & Medical Oncology;2011, Vol. 3 Issue 4, p72 

    Hepatic resection is a potential curative therapy for selected hepatic malignancies. However, reserving an appropriate volume of future liver remnant (FLR) hampers adequate surgical resection in many cases. In order to keep a sufficient volume of FLR and to conduct effective surgery at the same...

  • Image-guided percutaneous ablation therapies for hepatocellular carcinoma. Shiina, Shuichiro // Journal of Gastroenterology;2009 Supplement 19, Vol. 44, p122 

    Image-guided percutaneous ablation therapies have been playing important roles in the treatment of hepatocellular carcinoma (HCC). In our department, we have treated 90% of previously untreated patients with ablation therapies. Among various local ablation therapies, radiofrequency ablation has...

  • Timing of Two-stage Liver Resection during Chemotherapy for Otherwise Unresectable Colorectal Metastases. Tanaka, Kuniya; Kumamoto, Takafumi; Nojiri, Kazunori; Takeda, Kazuhisa; Ichikawa, Yasushi; Endo, Itaru // World Journal of Surgery;Aug2012, Vol. 36 Issue 8, p1832 

    Background: Tumor downsizing by effective chemotherapy while increasing remnant liver volume by two-stage hepatectomy can expand eligibility for resection of otherwise unresectable liver metastases. However, optimal timing of two-stage hepatectomy with respect to chemotherapy is undetermined....

  • Laparoscopic liver resection for treating recurrent hepatocellular carcinoma. Kanazawa, Akishige; Tsukamoto, Tadashi; Shimizu, Sadatoshi; Kodai, Shintaro; Yamamoto, Satoshi; Yamazoe, Sadaaki; Ohira, Go; Nakajima, Takayoshi // Journal of Hepato -- Biliary -- Pancreatic Sciences;Jun2013, Vol. 20 Issue 5, p512 

    Background: It is still unknown whether laparoscopic liver resection is suitable for recurrent hepatocellular carcinoma (HCC) after previous curative hepatic resection. Method: The perioperative outcomes of 40 patients treated with second surgery for recurrent HCC by partial hepatectomy were...

  • Selective Portal Vein Embolization as Introduction in Major Surgery. Matela, Jože; Zabavnik, Zoran; Jukić, Tomislav; Jukić, Dubravko; Glavina, Krešimir; Tušek-Bunc, Ksenija; Pavan-Jukić, Doroteja // Collegium Antropologicum;Jun2005, Vol. 29 Issue 1, p163 

    In the period between the December 2000 and September 2004, altogether 13 patients underwent preoperative portal vein embolization (PPVE); 9 patients with colorectal metastases and 4 patients with hepatocellular carcinoma. The indirect splenic portography was performed after catheter was...

  • Right trisegmentectomy with thoracoabdominal approach after transarterial embolization for giant hepatic hemangioma. Hyung-Il Seo; Hong Jae Jo; Mun Sup Sim; Suk Kim; Takayama, Tadatoshi // World Journal of Gastroenterology;7/21/2009, Vol. 15 Issue 27, p3437 

    Hepatic hemangiomas need to be treated surgically in cases where they are accompanied with symptoms, have a risk of rupture, or are hardly distinguishable from malignancy. The present authors conducted embolization of the right hepatic artery one day before an operation for a huge hemangioma...

  • Quimioembolización intraarterial hepática supraselectiva transitoria en pacientes con hepatocarcinoma o metástasis a hígado con primario controlado. Bracho, Madelaine Lucia; Enríquez, Jesús Solier Insuasty; Saaibi, José Federico; Hernández, Germán Gamarra; M'comick, Alexander // MedUNAB;sep2008, Vol. 11 Issue 2, p95 

    Background: There is no standard treatment for patients with unresectable primary liver carcinoma or liver metastasic cancer with controlled primary and failed systemic treatment. Methodology: Review charts from six patients treated with liver intraarterial transient supraselective...

  • TACE, sorafenib improve survival among patients with infiltrative hepatocellular carcinoma.  // Hem/Onc Today;9/10/2013, Vol. 14 Issue 17, p18 

    The article discusses a study published in a 2013 issue of the journal "Clinical Gastroenterology and Hepatology" that examined the effectiveness of transarterial chemoembolization (TACE) or sorafenib in improving survival among patients with infiltrative hepatocellular carcinoma.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics